Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Mol Oncol. 2013 Jan 19;7(3):555–566. doi: 10.1016/j.molonc.2013.01.003

Table 1.

Clinical characteristics of the study participants having prostate cancer

n Mean ± SE
Age 50 62.5 ± 0.8 (years)
PSA 51 8.7± 0.7 (ng/ml)
BCR Time 59 34.1± 3.7 (months)
Survival Time 59 50.3 ± 4.2 (months)

PSA=prostate specific antigen; BCR: biochemical recurrence